Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 3 | |
Outperform | 5 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for SpringWorks Therapeutics Inc have a median target of 63.13, with a high estimate of 80.00 and a low estimate of 58.00. The median estimate represents a 85.73% increase from the last price of 33.99.
High | 135.4% | 80.00 |
Med | 85.7% | 63.13 |
Low | 70.6% | 58.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 12, 2024.
Average growth rate | +14.27% |
Average growth rate | -53.74% |
More ▼
Revenue history & estimates in USD
Average growth rate | +61.45% |
Average growth rate | -50.00% |
More ▼